NO20021212L - Taxan prodroger - Google Patents

Taxan prodroger

Info

Publication number
NO20021212L
NO20021212L NO20021212A NO20021212A NO20021212L NO 20021212 L NO20021212 L NO 20021212L NO 20021212 A NO20021212 A NO 20021212A NO 20021212 A NO20021212 A NO 20021212A NO 20021212 L NO20021212 L NO 20021212L
Authority
NO
Norway
Prior art keywords
polyethylene glycol
prodrugs
taxan
group
forming unit
Prior art date
Application number
NO20021212A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021212D0 (no
Inventor
Nnochiri N Ekwuribe
Gary S Bartley
Christopher H Price
Original Assignee
Nobex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobex Corp filed Critical Nobex Corp
Publication of NO20021212D0 publication Critical patent/NO20021212D0/no
Publication of NO20021212L publication Critical patent/NO20021212L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20021212A 1999-09-13 2002-03-12 Taxan prodroger NO20021212L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15357999P 1999-09-13 1999-09-13
US09/476,974 US6380405B1 (en) 1999-09-13 1999-12-31 Taxane prodrugs
PCT/US2000/024523 WO2001019407A2 (en) 1999-09-13 2000-09-07 Taxane prodrugs

Publications (2)

Publication Number Publication Date
NO20021212D0 NO20021212D0 (no) 2002-03-12
NO20021212L true NO20021212L (no) 2002-05-13

Family

ID=26850672

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021212A NO20021212L (no) 1999-09-13 2002-03-12 Taxan prodroger

Country Status (16)

Country Link
US (1) US6380405B1 (cs)
EP (1) EP1214096A2 (cs)
JP (1) JP2003509386A (cs)
KR (1) KR20020082458A (cs)
CN (1) CN1390142A (cs)
AU (2) AU784395B2 (cs)
BR (1) BR0013949A (cs)
CA (1) CA2384646A1 (cs)
CZ (1) CZ2002929A3 (cs)
HK (1) HK1046856A1 (cs)
HU (1) HUP0300093A2 (cs)
IL (1) IL148559A0 (cs)
MX (1) MXPA02002711A (cs)
NO (1) NO20021212L (cs)
PL (1) PL354779A1 (cs)
WO (1) WO2001019407A2 (cs)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713454B1 (en) * 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
US6541508B2 (en) * 1999-09-13 2003-04-01 Nobex Corporation Taxane prodrugs
KR100406739B1 (ko) * 2000-04-15 2003-11-20 주식회사 코오롱 파클리탁셀 또는 이의 유도체의 잔기를 포함하는 수용성프로드럭 화합물, 그의 제조 방법 및 그를 포함하는 약제조성물
MXPA04003597A (es) 2001-10-18 2004-07-30 Nektar Therapeutics Al Corp Conjugados polimericos de antagonistas opiaceos.
US6593334B1 (en) 2002-05-02 2003-07-15 The University Of North Carolina At Chapel Hill Camptothecin-taxoid conjugates as antimitotic and antitumor agents
GR1004274B (el) * 2002-07-16 2003-06-23 Medexis ���� Συμπλοκα στεροειδων ορμονων με πρωτεινες: νεες ουσιες για την ειδικη ανιχνευση και καταστροφη καρκινικων κυτταρων προερχομενων απο στερεους ογκους και αιματολογικες κακοηθειες
CN1678296A (zh) * 2002-07-30 2005-10-05 卡里凯昂公司 依泽替米贝的组合物和治疗胆固醇有关的良性与恶性肿瘤的方法
AU2003303090A1 (en) * 2002-08-16 2004-08-13 University Of Massachusetts Pyridine and related ligand compounds, functionalized nanoparticulate composites and methods of preparation
AU2002951833A0 (en) * 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US20040152769A1 (en) * 2002-11-09 2004-08-05 Ekwuribe Nnochiri Nkem Modified carbamate-containing prodrugs and methods of synthesizing same
AU2004262906B2 (en) 2003-07-23 2008-04-03 Nordic Bioscience A/S Use of calcitonin in osteoarthritis
EP1686981A4 (en) * 2003-11-19 2011-02-23 Novogen Res Pty Ltd COMPOSITIONS AND METHODS FOR COMBINED RADIATION THERAPY AND CHEMOTHERAPY
US7786133B2 (en) * 2003-12-16 2010-08-31 Nektar Therapeutics Chemically modified small molecules
US20060182692A1 (en) * 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
DK1720540T3 (da) 2004-02-18 2008-10-06 Gpc Biotech Ag Satraplatin til behandling af resistente tumorer eller tumorer, der er vanskelige at behandle
AU2005251691A1 (en) * 2004-05-17 2005-12-22 Tekmira Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
WO2006002119A2 (en) 2004-06-18 2006-01-05 Gpc Biotech, Inc. Kinase inhibitors for treating cancers
US8329958B2 (en) 2004-07-02 2012-12-11 Biocon Limited Combinatorial synthesis of PEG oligomer libraries
US20060135468A1 (en) 2004-09-02 2006-06-22 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using NA+/K+ ATPase inhibitors
CA2581125C (en) 2004-09-22 2013-04-23 Nippon Kayaku Kabushiki Kaisha Modified poly(ethylene oxide-amino acid) copolymer, micelle preparation, and anticancer agent containing the same
WO2006042056A2 (en) * 2004-10-08 2006-04-20 The Ohio State University Methods and compositions for enzyme-specific activation of carbohydrate-conjugated prodrugs
CN100361985C (zh) * 2004-10-26 2008-01-16 中国科学院长春应用化学研究所 可生物降解聚合物的紫杉醇前药及其合成方法
JP2008543789A (ja) * 2005-06-17 2008-12-04 ホスピラ オーストラリア ピーティーワイ エルティーディー ドセタキセルの液体薬学的処方物
CN1895676B (zh) * 2005-07-14 2010-11-10 上海艾力斯医药科技有限公司 聚乙二醇为载体的紫杉醇或多烯紫杉醇的前药
AU2006318815B2 (en) 2005-11-17 2010-08-19 Novartis Ag Pharmaceutical composition
CN100431610C (zh) * 2006-01-24 2008-11-12 中国科学院长春应用化学研究所 两亲性三嵌段共聚物-紫杉醇键合药及其制备方法
US8323669B2 (en) 2006-03-28 2012-12-04 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of taxane
CN101448875A (zh) 2006-05-18 2009-06-03 日本化药株式会社 鬼臼毒素类的高分子量结合体
WO2008056596A1 (en) 2006-11-06 2008-05-15 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
EP2090607B1 (en) 2006-11-08 2015-05-20 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
WO2008106640A1 (en) * 2007-03-01 2008-09-04 Cedars-Sinai Medical Center Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
WO2009017662A2 (en) * 2007-07-27 2009-02-05 Immuneregen Biosciences, Inc. Method of using substance p analogs for treatment amelioration of myelodysplastic syndrome
EP2206502B1 (en) 2007-09-28 2018-09-12 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of steroid
US9028874B2 (en) * 2008-01-03 2015-05-12 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
EP2258397B1 (en) 2008-03-18 2017-10-11 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of physiologically active substance
EP2284209B1 (en) 2008-05-08 2016-08-31 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of folic acid or folic acid derivative
WO2009148698A1 (en) * 2008-06-02 2009-12-10 Cedars-Sinai Medical Center Nanometer-sized prodrugs of nsaids
EP2370435B1 (en) 2008-11-24 2015-01-07 Cedars-Sinai Medical Center Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof
WO2010105016A1 (en) 2009-03-11 2010-09-16 Ambit Biosciences Corp. Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment
WO2010131675A1 (ja) 2009-05-15 2010-11-18 日本化薬株式会社 水酸基を有する生理活性物質の高分子結合体
NZ609874A (en) 2010-09-30 2014-10-31 Astrazeneca Ab Crystalline naloxol-peg conjugate
CA2816997A1 (en) 2010-11-17 2012-05-24 Nippon Kayaku Kabushiki Kaisha Novel polymer derivative of cytidine metabolic antagonist
CN103607888A (zh) * 2011-04-08 2014-02-26 斯法尔制药私人有限公司 取代的甲基甲酰基试剂以及使用所述试剂改进化合物的物理化学性质和/或药代动力学性质的方法
CN102276826B (zh) * 2011-06-03 2013-01-02 中国科学院长春应用化学研究所 抗肿瘤前药及其制备方法
KR101849142B1 (ko) 2011-09-11 2018-04-16 니폰 가야꾸 가부시끼가이샤 블록 공중합체의 제조방법

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411947A (en) 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
US5407683A (en) 1990-06-01 1995-04-18 Research Corporation Technologies, Inc. Pharmaceutical solutions and emulsions containing taxol
AU4406793A (en) 1992-06-04 1993-12-30 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
US5614549A (en) * 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
WO1994005282A1 (en) 1992-09-04 1994-03-17 The Scripps Research Institute Water soluble taxol derivatives
US5439686A (en) 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
AU6400094A (en) 1993-03-09 1994-09-26 Enzon, Inc. Taxol polyalkylene oxide conjugates of taxol and taxol intermediates
JPH0782291A (ja) 1993-09-13 1995-03-28 Microbial Chem Res Found 水溶性アンスラサイクリン誘導体
US5840900A (en) 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
US5824701A (en) * 1993-10-20 1998-10-20 Enzon, Inc. Taxane-based prodrugs
US5880131A (en) 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
HU226646B1 (en) 1996-03-12 2009-05-28 Pg Txl Company Water soluble pharmaceutical compositions containing taxane derivatives
CA2251742C (en) 1996-04-15 2001-12-11 Asahi Kasei Kogyo Kabushiki Kaisha Drug complex
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
WO1998058927A1 (en) 1997-06-20 1998-12-30 Baker Norton Pharmaceuticals, Inc. Soluble prodrugs of paclitaxel
EP1037649B1 (en) 1997-12-17 2009-09-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
AU748496B2 (en) * 1998-03-23 2002-06-06 Conjuchem, Inc. Local delivery of long lasting therapeutic agents
AU772074B2 (en) 1999-04-28 2004-04-08 Vectramed, Inc. Enzymatically activated polymeric drug conjugates
WO2001013957A2 (en) 1999-08-24 2001-03-01 Cellgate, Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs

Also Published As

Publication number Publication date
CN1390142A (zh) 2003-01-08
CA2384646A1 (en) 2001-03-22
NO20021212D0 (no) 2002-03-12
WO2001019407A3 (en) 2002-01-17
JP2003509386A (ja) 2003-03-11
BR0013949A (pt) 2002-05-14
IL148559A0 (en) 2002-09-12
AU2006202613A1 (en) 2006-07-13
AU6951200A (en) 2001-04-17
PL354779A1 (en) 2004-02-23
HK1046856A1 (zh) 2003-01-30
EP1214096A2 (en) 2002-06-19
AU784395B2 (en) 2006-03-23
WO2001019407A2 (en) 2001-03-22
US6380405B1 (en) 2002-04-30
KR20020082458A (ko) 2002-10-31
MXPA02002711A (es) 2002-07-30
HUP0300093A2 (en) 2003-05-28
CZ2002929A3 (cs) 2002-08-14

Similar Documents

Publication Publication Date Title
NO20021212L (no) Taxan prodroger
TR199801629A2 (xx) Fungisidal 2 -metoksibenzofenonlar.
EE03400B1 (et) Fungitsiidid seentest Gaeumannomyces spp. põhjustatud taimede juuremädaniku vastu
AU9744298A (en) Substituted tetrahydronaphthaline and analogous compounds
WO2002072010A3 (en) Taxane prodrugs
NO20052975D0 (no) Nye 2',5'-oligoadenylsyreanaloger.
ITBO990289A0 (it) Apparecchiatura per la realizzazione di cornici rettangolari .
NO20006525L (no) Systemmodul, spesielt for forsvarsformål
ITBO990227A0 (it) Macchina per la lavorazione di pannelli di legno o similari .
WO2001046128A3 (en) Tryptase inhibitors
DE69829082D1 (de) 2,4,4-trisubstituierte-1,3-dioxolan fungizide
ITBO990458A0 (it) Apparecchiatura per la realizzazione di cornici rettangolari .
NL194514B (nl) Camerakraan, alsmede zwaartekracht-corrigerende middelen hiervoor.
FI110661B (fi) Menetelmä eloperäisen materiaalin, kuten rehun, säilömiseksi
ITBO990226A0 (it) Macchina per la lavorazione di pannelli di legno o similari .
IT1223703B (it) Carrello per il trasporto di organi di macchine agricole particolarmente piattaforme di taglio di macchine mietitrebbiatrici
FR2666722B1 (fr) Procede pour lutter contre venturia.
IT245544Y1 (it) Struttura di toro particolarmente per gradini o pareti.
ITPD20000182A0 (it) Struttura di attrezzaggio per pareti o pannelli.
IT1319660B1 (it) Processo per la preparazione di 1-(1-amminoalchil)ossirani protetti.
IT249916Y1 (it) Poggiapuntale portatile universale per violoncello.
AU3063900A (en) Improved guard for tree or plant
ITRM20010453A0 (it) Macchina perfezionata per la raccolta di frutti da terra.
ITRM990440A0 (it) Impianto di decapaggio e sbianca per laminati.
NO20026187D0 (no) Fremgangsmåte for identifisering av tömmerstokkers ytre mål for lafting meddimensjonsvariable emner, samt anvendelse av fremgangsmåten